ICICI Prudential Nifty Pharma ETF

ICICI Prudential Mutual Fund · Equity ETFs · Regular Growth · AMFI 154804 · ISIN INF109K1A716
NAV₹28.374820 Nov 2026
3Y return—a year
5Y return—a year
Expense ratio5.70%₹6 Cr
Growth Score—

Returns

1M3M6MYTD1Y3Y5Y7Y10YSince launch
Fund+10.14%————————+10.14%
NIFTY Pharma TRI+10.82%+7.43%+14.54%+25.40%+25.57%+22.02%+16.60%———
Category middle+9.44%+2.23%+7.03%+1.53%+0.66%+11.16%+8.98%+12.69%+13.37%—

Risk (36 months)

Volatility—
Sharpe—
Sortino—
Beta—
Alpha—
Deepest fall-2.74%
1-year periods with a loss—
5Y SIP XIRR—

Top holdings (31 Oct 2026)

Sun Pharmaceutical Industries Ltd.18.62%
Divi's Laboratories Ltd.12.29%
Laurus Labs Ltd.9.27%
Dr. Reddy's Laboratories Ltd.8.15%
Cipla Ltd.7.67%
Torrent Pharmaceuticals Ltd.6.71%
Lupin Ltd.4.83%
Aurobindo Pharma Ltd.4.60%
Glenmark Pharmaceuticals Ltd.3.42%
Zydus Lifesciences Ltd.3.05%
Alkem Laboratories Ltd.3.05%
Mankind Pharma Ltd.2.79%

Sectors

Pharmaceuticals & Biotechnology100.0%

Calculated by Growth Analyser from AMFI NAVs and the fund house's disclosed portfolio. Up to 1 year: total return; longer: CAGR. Research and education only; not investment advice. Mutual fund investments are subject to market risks; read all scheme-related documents carefully. Past performance does not indicate future returns.